These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7990266)

  • 1. A useful method for differential evaluation of anti-inflammatory effects due to cyclooxygenase and 5-lipoxygenase inhibitions in mice.
    Ishii K; Motoyoshi S; Kawata J; Nakagawa H; Takeyama K
    Jpn J Pharmacol; 1994 Aug; 65(4):297-303. PubMed ID: 7990266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
    Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
    Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfidopeptide-leukotrienes are major mediators of arachidonic acid-induced mouse ear edema.
    Inoue H; Mori T; Koshihara Y
    Prostaglandins; 1988 Nov; 36(5):731-9. PubMed ID: 3148965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of corticosterone in modulation of eicosanoid biosynthesis and antiinflammatory activity by 5-lipoxygenase (5-LO) and cyclooxygenase (CO) inhibitors.
    Tomchek LA; Hartman DA; Lewin AC; Calhoun W; Chau TT; Carlson RP
    Agents Actions; 1991 Sep; 34(1-2):20-4. PubMed ID: 1665293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.
    Carlson RP; O'Neill-Davis L; Chang J; Lewis AJ
    Agents Actions; 1985 Dec; 17(2):197-204. PubMed ID: 3938181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of leukotriene production by N-[4-[4-(diphenylmethyl)-1- piperazinyl]butyl]-3-(6-methyl-3-pyridyl) acrylamide (AL-3264), a new antiallergic agent.
    Ishii K; Yakuo I; Motoyoshi S; Nakagawa H; Nakamura H
    Jpn J Pharmacol; 1994 May; 65(1):19-25. PubMed ID: 7916384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of action of the new antiinflammatory compound ML3000: inhibition of 5-LOX and COX-1/2.
    Tries S; Neupert W; Laufer S
    Inflamm Res; 2002 Mar; 51(3):135-43. PubMed ID: 12005204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
    Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
    J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
    Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of prostaglandin H synthase isoforms in murine ear edema induced by phorbol ester application on skin.
    Sánchez T; Moreno JJ
    Prostaglandins Other Lipid Mediat; 1999 May; 57(2-3):119-31. PubMed ID: 10410383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tebufelone (NE-11740), a new anti-inflammatory drug, on arachidonic acid metabolism.
    Weisman SM; Doyle MJ; Wehmeyer KR; Hynd BA; Eichhold TH; Clear RM; Coggeshall CW; Kuhlenbeck DL
    Agents Actions; 1994 May; 41(3-4):156-63. PubMed ID: 7942323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extract and compounds obtained from Mandevilla velutina inhibit arachidonic acid-induced ear oedema in mice, but not rat stomach contraction.
    Calixto JB; Zanini Júnior JC; Cruz AB; Yunes RA; Medeiros YS
    Prostaglandins; 1991 May; 41(5):515-26. PubMed ID: 1907393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an anti-inflammatory peptide (antiflammin 2) on cell influx, eicosanoid biosynthesis and oedema formation by arachidonic acid and tetradecanoyl phorbol dermal application.
    Lloret S; Moreno JJ
    Biochem Pharmacol; 1995 Jul; 50(3):347-53. PubMed ID: 7646536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings.
    Engelhardt G; Bögel R; Schnitzler C; Utzmann R
    Biochem Pharmacol; 1996 Jan; 51(1):29-38. PubMed ID: 8534265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of topically applied cyclosporin A on arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation in mouse ear.
    Puigneró V; Queralt J
    Inflammation; 1997 Jun; 21(3):357-69. PubMed ID: 9246577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte recruitment in the subcutaneous sponge implant model of acute inflammation in the rat is not mediated by leukotriene B1.
    Foster SJ; McCormick ME; Howarth A; Aked D
    Biochem Pharmacol; 1986 May; 35(10):1709-17. PubMed ID: 3011012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgetic activity of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.
    Griswold DE; Marshall P; Martin L; Webb EF; Zabko-Potapovich B
    Agents Actions Suppl; 1991; 32():113-7. PubMed ID: 1906235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
    Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
    Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
    Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.